Help
RSS
API
Feed
Maltego
Contact
Domain > www.ontruzant.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2021-07-27
13.225.209.21
(
ClassC
)
2026-01-18
192.0.66.221
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyServer: nginxDate: Wed, 24 Jul 2024 19:42:25 GMTContent-Type: text/htmlContent-Length: 162Connection: keep-aliveLocation: https://www.ontruzant.com/x-rq: sea4 html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>nginx/center>/body>/html>
Port 443
HTTP/1.1 200 OKServer: nginxDate: Wed, 24 Jul 2024 19:42:25 GMTContent-Type: text/html; charsetUTF-8Content-Length: 39169Connection: keep-aliveVary: Accept-EncodingX-Powered-By: ExpressAccess-Control- !DOCTYPE html>html langen>head> meta charsetutf-8> meta nameviewport contentwidthdevice-width, initial-scale1.0> meta nameformat-detection contenttelephoneno>title>ONTRUZANT® (trastuzumab-dttb) | Official Site/title>meta namedescription contentLearn about ONTRUZANT®(trastuzumab-dttb) and how it may help in your treatment of HER2+ breast cancer.>meta namekeywords contentontruzant, trastuzumab-dttb, her2 positive breast cancer treatment>link relcanonical hrefhttps://www.ontruzant.com/>script typeapplication/ld+json>{@context:http://schema.org/,url:https://www.ontruzant.com/,@type:Drug,proprietaryName:ONTRUZANT®,nonProprietaryName:trastuzumab-dttb,manufacturer:Organon}/script>script typeapplication/ld+json>{@context:http://schema.org/,url:https://www.ontruzant.com/,@type:MedicalAudience,audienceType:Patient,geographicArea:This site is intended only for residents of the United States, its territories, and Puerto Rico.}/script> link relstylesheet typetext/css mediaall hrefstatic/css/main.css /> link relapple-touch-icon hrefapple-touch-icon.png> link relicon typeimage/png sizes32x32 hreffavicon-32x32.png> link relicon typeimage/png sizes16x16 hreffavicon-16x16.png> link relmanifest hrefmanifest.json>!-- Google Tag Manager -->script>(function(w,d,s,l,i){wlwl||;wl.push({gtm.start:new Date().getTime(),event:gtm.js});var fd.getElementsByTagName(s)0,jd.createElement(s),dll!dataLayer?&l+l:;j.asynctrue;j.srchttps://www.googletagmanager.com/gtm.js?id+i+dl;f.parentNode.insertBefore(j,f);})(window,document,script,dataLayer,GTM-PXFNR5F);/script>!-- End Google Tag Manager -->!-- START - OneTrust Cookies Consent Notice for ontruzant consumer site --> script srchttps://cdn.cookielaw.org/scripttemplates/otSDKStub.js typetext/javascript charsetUTF-8 data-domain-script80abca6e-bc42-493f-8285-ac168b41ef30>/script> script typetext/javascript> function OptanonWrapper() { } /script>!-- END - OneTrust Cookies Consent Notice for ontruzant consumer site -->script srchttps://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]